Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucin production in conjunctival goblet cells and corneal epithelia is essential for maintaining a healthy ocular surface. Goblet cells secrete gel-forming mucins, primarily MUC5AC, which contribute to tear film stability and lubrication. Corneal and conjunctival epithelial cells produce transmembrane mucins like MUC1, MUC4, and MUC16, forming a glycocalyx that protects the ocular surface and promotes tear film adhesion. Dysregulation of mucin production is implicated in various ocular surface diseases, most notably dry eye disease. Treatments aim to restore or modulate mucin synthesis and secretion to alleviate symptoms and improve ocular surface health.
N/A
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin Production in Conjunctival Goblet Cells and Corneal Epithelia (N/A).